Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Mayo Clinic
University of Arizona
British Columbia Cancer Agency
University of Florida
Excel Diagnostics and Nuclear Oncology Center
National Cancer Institute (NCI)
University of Southern California
Yale University